Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Does the presence of a BRCA 1/2 mutation affect your recommendation for post-mastectomy RT in patients with pT1-2, N0 disease?
Answer from: Radiation Oncologist at Community Practice
It doesn’t influence RT decision.
Sign in or Register to read more
11230
Related Questions
With the presentation of HypoG-01 phase III UNICANCER trial at ESMO 2024, should hypofractionated radiotherapy be the standard across the board for breast cancer?
What is your preferred method of surveillance after mastectomy?
Under what circumstances would you offer PMRT in a patient with DCIS?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
When treating APBI with the Florence regimen, are you using daily or every other day fractionation?
What dose of reirradiation would you consider for locally recurrent breast cancer after mastectomy, excised with positive margins?
When treating chestwall + RNI with VMAT, how much do you crop the PTV into lung as is done with the PTVeval in 3D contouring guides?
Would you offer ultra-hypofractionated accelerated partial breast re-irradiation using 5 fractions?
Is keratosis follicularis (Darier disease) a contraindication to receipt of PMRT?
How would you treat a young breast cancer patient with limited nodal involvement and an isolated sternal oligometastasis at diagnosis?